Company facts
- Headquarters
- Cambridge, Massachusetts
- Most recent report
- 10-Q, filed Aug 5, 2026
- Incorporated
- Delaware
- Filings on record
- 715 filings
- On EDGAR
- CIK 1650664
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer Smaller reporting company
Financials 8 of 44
News 8 of 131
Prospectuses and Registrations 8 of 36
- 424B5 Prospectus supplement for an offering May 26, 2026
- 424B5 Prospectus supplement for an offering May 26, 2026
- POS AM Post-effective amendment to a registration Mar 5, 2025
- S-8 Registration statement for an employee plan Mar 5, 2025
- S-3ASR Automatic shelf registration Feb 28, 2024
- S-8 Registration statement for an employee plan Feb 28, 2024
- 424B5 Prospectus supplement for an offering Jun 15, 2023
- 424B5 Prospectus supplement for an offering Jun 14, 2023
Proxies 8 of 23
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- DEFA14A Extra proxy material Apr 15, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 15, 2025
- PRE 14A Preliminary proxy statement Apr 4, 2025
- DEFA14A Extra proxy material Apr 16, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 16, 2024
- DEFA14A Extra proxy material Apr 18, 2023
Ownership 8 of 430
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- 4 Insider reported a trade Aug 7, 2026
- 3 Insider reported their initial holding Aug 7, 2026
- 4 Insider reported a trade Aug 5, 2026
- 4 Insider reported a trade Jul 29, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 29, 2026
- 144 Notice of a proposed sale of restricted stock Jul 21, 2026
- 4 Insider reported a trade Jun 22, 2026
Other 8 of 51
Everything here comes from Editas Medicine, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.